MEDP
MEDP
NASDAQ · Life Sciences Tools & Services

Medpace Holdings Inc

$624.20
+11.87 (+1.94%)
Analyst Consensus
Hold
20
Analysts
High
Coverage
Buy 7 35%
Hold 12 60%
Sell 1 5%
Price Target
Analyst Price Target -77.8% upside
Low Target $83.02
Average Target $138.38
High Target $160.10
Current Price $624.20
Current
$624.20
Target
$138.38
$83.02 $138.38 avg $160.10
Scenario Analysis
Bear Case
$83.02
-86.7%
Low target
Base Case
$138.38
-77.8%
Avg target
Bull Case
$160.10
+-74.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$677.90
-7.9% from high
52-Week Low
$373.00
+67.3% from low
50-Day SMA
$559.05
+11.7% vs SMA
200-Day SMA
$472.19
+32.2% vs SMA
RSI (14)
16.7
Oversold
Target vs 52W High
$138.38
-79.6% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -43.9%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -28.4%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.3%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -60.1%
WAT
Waters Corp
Buy 31 65% $189.60 -55.3%
ILMN
Illumina Inc
Buy 28 57% $169.36 -29.1%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -88.1%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -62.3%